Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.1B | 7.2B | 7.0B | 6.8B |
| Cost of revenue | — | 3.7B | 3.7B | 3.6B |
| Gross profit | — | 3.5B | 3.3B | 3.2B |
| Operating expense | ||||
| Research & development | — | 859M | 858M | 836M |
| Selling general and admin | — | 462M | 431M | 427M |
| Other operating expenses | — | — | — | — |
| Operating income | — | 2.2B | 2.0B | 1.9B |
| Non operating interest income | ||||
| Income | — | 8M | -85M | 81M |
| Expense | — | 64M | 66M | 63M |
| Other income expense | — | — | — | — |
| Pretax income | — | 2.1B | 1.9B | 2.0B |
| Tax provision | — | 934M | 164M | 255M |
| Net income | — | 1.2B | 1.7B | 1.7B |
| Basic EPS | — | 0.1 | 0.2 | 0.2 |
| Diluted EPS | — | 0.1 | 0.2 | 0.2 |
| Basic average shares | — | 8.1B | 8.2B | 8.3B |
| Diluted average shares | — | 8.2B | 8.3B | 8.3B |
| EBITDA | — | 2.3B | 2.1B | 2.1B |
| Net income from continuing op. | — | 1.2B | 1.7B | 1.7B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |